J&J restructure skirts Australia

Updated: Johnson & Johnson is being tight-lipped about the extent to which local employees may be affected by its decision to wind down its cardiovascular and metabolic drug unit globally, however the Australian arm does not market the drug most affected by the change.

To see the whole article please log in.

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here